Impact of COVID-19 on primary percutaneous coronary intervention centres in the UK: a survey
Ahmed M Adlan1, Ven G Lim2, Gurpreet Dhillon3
1Senior Cardiology Fellow in Electrophysiology and Devices North West Heart Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT.
Insights
The COVID-19 pandemic significantly reduced open cardiac catheterization labs in the UK, impacting primary percutaneous coronary intervention (PCI) services. However, primary PCI remained the preferred treatment for ST-elevation myocardial infarction (STEMI) patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Public Health
Background:
- The COVID-19 pandemic prompted recommendations to postpone elective procedures.
- Primary percutaneous coronary intervention (PCI) is the recommended treatment for ST-elevation myocardial infarction (STEMI).
Purpose of the Study:
- To assess the impact of the COVID-19 pandemic on primary PCI services in the United Kingdom.
- To evaluate changes in cardiac catheterization laboratory availability during the pandemic.
Main Methods:
- A survey was conducted across 43 primary PCI centers in the UK.
- Data on the number of open cardiac catheterization labs before and during the COVID-19 pandemic were collected.
Main Results:
- A significant reduction in open cardiac catheterization labs was observed (3.6±1.8 pre-COVID vs. 2.1±0.8 post-COVID).
- Only 64% of cardiac catheterization labs remained operational during the pandemic.
- Primary PCI was consistently maintained as the first-line treatment for STEMI across all surveyed centers.
Conclusions:
- The COVID-19 pandemic led to a substantial decrease in operational cardiac catheterization labs.
- Despite reduced capacity, primary PCI remained the standard of care for STEMI patients in the UK.
Abstract:
During the coronavirus disease (COVID-19) pandemic, the British Cardiovascular Society/British Cardiovascular Intervention Society and the British Heart Rhythm Society recommended to postpone non-urgent elective work and that primary percutaneous coronary intervention (PCI) should remain the treatment of choice for patients with ST-segment elevation myocardial infarction (STEMI). We sought to determine the impact of COVID-19 on the primary PCI service within the United Kingdom (UK). A survey of 43 UK primary PCI centres was performed and a significant reduction in the number of cath labs open was found (pre-COVID 3.6±1.8 vs. post-COVID 2.1±0.8; p<0.001) with only 64% of cath labs remained open during the COVID-19 pandemic. Primary PCI remained first-line treatment for STEMI in all centres surveyed.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome III: Diagnostic Studies


